PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

December 17th , 2009 Issue 38 Vol. 16
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Congress Questions Pharma Price Hikes
Transparency can be a double-edged sword—especially if you are a doctor receiving money to speak on behalf of a drug company. Sure the payday is nice, but does the public outing open you up to scrutiny?
» MORE

Sanofi Gets a Bad Batch of H1N1 Vaccines
Sanofi-Aventis is recalling hundreds of thousands of doses of the childrens’ version of its H1N1 vaccine. Conspiracy theorists are going to have a field day.
» MORE

Gilead and Elan Struggle with Clinical Trials
It’s been a tough week for clinical trials: One drug got canned and another was re-tuned in the wake of failed end points and patient deaths.
» MORE

PharmRep Direct Features

Drug Topics' 2010 Pharmacy Business Outlook survey
Gloom may pervade much of the economy, but the pharmacy business is strong, and despite some challenges, will remain so
» MORE

2010 Forecast: Key Products and Leading Therapeutic Classes
Alexandra Kibble of Thomson Reuters identifies the products and therapy areas to watch next year
» MORE

Ushering in a New Phase in Corporate Social Responsibility
Pharmaceutical and biotech companies get together to discuss corporate social responsibility at a United Nations forum
» MORE


 
FindPharma   Search
 
Subscribe To PharmRep Today!
PharmRep Direct Survey, Vote Today!
The more people talk about healthcare reform the less consensus there is, what do you think of current efforts to reform the system?
Click Here to Vote

PharmRep Direct Quick Links
Patients Opt Against Cancer Drug

Practicing Ideal Primary Care

Drug Pricing Debate


Follow Pharm Rep on Twitter



You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!